Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty
Rivaroxaban was superior to enoxaparin for thromboprophylaxis after total knee arthroplasty, with similar rates of bleeding. (ClinicalTrials.gov number, NCT00361894.)
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 1,286
- Institution
- Nordsjællands Hospital
External Links
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.